98%
921
2 minutes
20
Employing multivariate statistical methods, we aimed to construct and validate predictive models for distant metastasis (DM) risk and overall survival (OS) in patients with gallbladder cancer (GBC), using data from the surveillance, epidemiology, and end results database maintained by the National Cancer Institute. These models were visualized through the development of intuitive nomograms. We extracted clinical data of all patients diagnosed with GBC between 2010 and 2015 from the surveillance, epidemiology, and end results database. Both univariate and multivariate logistic regression analyses were conducted utilizing R software (Version 4.2.1) to identify independent risk predictors for DM in GBC patients, and univariate and multivariate Cox regression analyses were performed to determine independent prognostic factors for OS among GBC patients with DM. The discriminatory capabilities and predictive accuracies of the developed nomograms were examined through calibration curves, receiver operating characteristic curves, and decision curve analysis. In our study, 3071 patients with GBC were included, of which 759 (24.72%) had DM. Race, T stage, N stage, and tumor size were identified as independent risk factors for DM, while age, surgical intervention, and chemotherapy were independent prognostic factors for OS in GBC patients with DM. The area under the curve for the prognostic nomogram reached 0.726 and 0.730 in the training and validation sets, respectively. The area under the curve for the same nomogram at 6, 9, and 12 months was 0.744, 0.740, and 0.704 for the training set, and 0.798, 0.774, and 0.776 for the validation set, respectively. The calibration curves, decision curve analysis, and Kaplan-Meier survival curves further demonstrated the effectiveness of the nomograms in predicting DM occurrence and the prognosis of GBC patients with DM. Race, T stage, N stage, and tumor size emerged as independent risk factors for DM in GBC patients; whereas age, surgical treatment, and chemotherapy were found to be independent prognostic factors for OS in GBC patients with DM. We successfully established and validated a predictive nomogram for DM occurrence and a prognostic nomogram for OS in GBC patients with DM, both showing high accuracy and clinical utility.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12282738 | PMC |
http://dx.doi.org/10.1097/MD.0000000000043369 | DOI Listing |
Eur J Surg Oncol
July 2025
General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, PISA, Italy.
Introduction: Surgery for resectable gallbladder cancer (GbC) encompasses complex operative management, and evaluating surgical quality through textbook outcome (TO) is crucial. This study aimed to assess TO incidence and impact in a global cohort, identify independent predictors, and evaluate TO rates of minimally invasive (MI) techniques, including robotic (ROB) and laparoscopic (LPS).
Materials And Methods: This cohort study included patients undergoing curative-intent hepatectomy and lymphadenectomy for GbC (T1b-T3) from 2012 to 2023 in 41 hospitals.
J Surg Oncol
September 2025
Department of Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Background And Objectives: The current staging for gallbladder cancer (GBC) considers only the number of metastatic lymph nodes without addressing their location. This study evaluates the prognostic impact of lymph node mapping (both number and location) in node positive GBC.
Methods: Prospectively maintained operative database of operated GBC patients from April 2010 to March 2022 with positive lymph nodes was analyzed.
Insights Imaging
August 2025
Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Objectives: To predict tertiary lymphoid structures (TLSs) in gallbladder cancer (GBC) using preoperative magnetic resonance imaging (MRI)-based radiomics.
Methods: Patients with GBC from two centres served as training (n = 129) and external validation (n = 44) cohorts. Radiomics features were extracted from six imaging sequences for inclusion in a radiomics model (Rad-score).
Acta Biochim Biophys Sin (Shanghai)
August 2025
Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Gemcitabine resistance poses a significant challenge in gallbladder cancer (GBC) treatment, necessitating exploration of its molecular mechanisms. This study focuses on DDX11, which is highly expressed in gemcitabine-resistant GBC cells, suggesting a potential role in DNA damage repair. We establish gemcitabine-resistant GBC cell lines and observe significantly higher DDX11 expression in these cells than in parental cells.
View Article and Find Full Text PDFBiol Direct
August 2025
Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi Province, 710061, China.
Background & Aims: Gallbladder cancer (GBC) is characterised by a desmoplastic microenvironment rich in collagen fibres and extracellular matrix, contributing to increased matrix stiffness. SEMAs are overexpressed in various cancers but their expression and role in the crosstalk between activated gallbladder fibroblasts (GFs) and GBC cells within a stiff microenvironment remain unclear. Herein, we aimed to elucidate the expression patterns and tumour-promoting effects of SEMAs in activated GFs under the matrix stiffness microenvironment.
View Article and Find Full Text PDF